Current and historical daily PE Ratio for Cellid Co Ltd (
XKRX:299660
) from 2019 to Apr 26 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Cellid stock (XKRX:299660) PE ratio as of Apr 26 2024 is 0.
More Details
Cellid Co Ltd (XKRX:299660) PE Ratio (TTM) Chart
Cellid Co Ltd (XKRX:299660) PE Ratio (TTM) Historical Data
View and export this data going back to 2019. Start your Free Trial
Total 1253
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Cellid PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-04-26 | At Loss | 2024-02-21 | At Loss |
| 2024-04-25 | At Loss | 2024-02-20 | At Loss |
| 2024-04-24 | At Loss | 2024-02-19 | At Loss |
| 2024-04-23 | At Loss | 2024-02-16 | At Loss |
| 2024-04-22 | At Loss | 2024-02-15 | At Loss |
| 2024-04-19 | At Loss | 2024-02-14 | At Loss |
| 2024-04-18 | At Loss | 2024-02-13 | At Loss |
| 2024-04-17 | At Loss | 2024-02-08 | At Loss |
| 2024-04-16 | At Loss | 2024-02-07 | At Loss |
| 2024-04-15 | At Loss | 2024-02-06 | At Loss |
| 2024-04-12 | At Loss | 2024-02-05 | At Loss |
| 2024-04-11 | At Loss | 2024-02-02 | At Loss |
| 2024-04-09 | At Loss | 2024-02-01 | At Loss |
| 2024-04-08 | At Loss | 2024-01-31 | At Loss |
| 2024-04-05 | At Loss | 2024-01-30 | At Loss |
| 2024-04-04 | At Loss | 2024-01-29 | At Loss |
| 2024-04-03 | At Loss | 2024-01-26 | At Loss |
| 2024-04-02 | At Loss | 2024-01-25 | At Loss |
| 2024-04-01 | At Loss | 2024-01-24 | At Loss |
| 2024-03-29 | At Loss | 2024-01-23 | At Loss |
| 2024-03-28 | At Loss | 2024-01-22 | At Loss |
| 2024-03-27 | At Loss | 2024-01-19 | At Loss |
| 2024-03-26 | At Loss | 2024-01-18 | At Loss |
| 2024-03-25 | At Loss | 2024-01-17 | At Loss |
| 2024-03-22 | At Loss | 2024-01-16 | At Loss |
| 2024-03-21 | At Loss | 2024-01-15 | At Loss |
| 2024-03-20 | At Loss | 2024-01-12 | At Loss |
| 2024-03-19 | At Loss | 2024-01-11 | At Loss |
| 2024-03-18 | At Loss | 2024-01-10 | At Loss |
| 2024-03-15 | At Loss | 2024-01-09 | At Loss |
| 2024-03-14 | At Loss | 2024-01-08 | At Loss |
| 2024-03-13 | At Loss | 2024-01-05 | At Loss |
| 2024-03-12 | At Loss | 2024-01-04 | At Loss |
| 2024-03-11 | At Loss | 2024-01-03 | At Loss |
| 2024-03-08 | At Loss | 2024-01-02 | At Loss |
| 2024-03-07 | At Loss | 2023-12-28 | At Loss |
| 2024-03-06 | At Loss | 2023-12-27 | At Loss |
| 2024-03-05 | At Loss | 2023-12-26 | At Loss |
| 2024-03-04 | At Loss | 2023-12-22 | At Loss |
| 2024-02-29 | At Loss | 2023-12-21 | At Loss |
| 2024-02-28 | At Loss | 2023-12-20 | At Loss |
| 2024-02-27 | At Loss | 2023-12-19 | At Loss |
| 2024-02-26 | At Loss | 2023-12-18 | At Loss |
| 2024-02-23 | At Loss | 2023-12-15 | At Loss |
| 2024-02-22 | At Loss | 2023-12-14 | At Loss |
Cellid Co Ltd (XKRX:299660) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Cellid Co Ltd
ISIN : KR7299660001
Share Class Description:
XKRX:299660: Ordinary SharesCompare
Compare
Traded in other countries / regions
299660.Korea IPO Date
2019-02-20Description
Cellid Co Ltd is a research and development bioventure company. The company is developing immunotherapeutic vaccines, CeliVax. The CeliVax is a personalized vaccine which uses patient's own cells.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers